We agree with the current opinion that TSHR mutations (except for those found at a high level) and/or NIS overexpression do not raise the probability of thyroid cancer or a pre-cancerous tumor, noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Here, TSHR is linked to neoplasm.